YK0901
/ Yingkai Saiwei (Beijing) Biotechnology
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 06, 2023
Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Solid Tumor
(clinicaltrials.gov)
- P1 | N=11 | Not yet recruiting | Sponsor: Peking University
Metastases • New P1 trial • Gastrointestinal Cancer • Oncology • Solid Tumor • KRAS
1 to 1
Of
1
Go to page
1